Drug
vedolizumab
Marketed as ENTYVIO.
Generic name
vedolizumab
Brand names
ENTYVIO
First FDA approval
2014-05-20
FDA approval history
| FDA ID | Brand | Approval date | Manufacturer |
|---|---|---|---|
| BLA761133 | ENTYVIO | 2023-09-27 | TAKEDA PHARMS USA |
| BLA125476 | ENTYVIO | 2014-05-20 | TAKEDA PHARMS USA |
Manufacturers
TAKEDA PHARMS USA
Frequently asked questions
When was vedolizumab FDA approved?
Earliest FDA approval on record: 2014-05-20.
What brand names are sold as vedolizumab?
ENTYVIO.
Sources
Appeal a vedolizumab denial
Upload your denial — DenialHelp drafts a physician-ready appeal letter in five minutes with the right clinical guideline and federal regulation cited. $39 first-level, money back if we can't draft a strong appeal.
Get started →Contact: hello@denialhelp.com